Treatment failure of community-acquired pneumonia: risk factors and consequences

A. Torres (Barcelona, Spain)

Source: Annual Congress 2012 - PG17 Clinical failure of treatment of respiratory infections
Session: PG17 Clinical failure of treatment of respiratory infections
Session type: Postgraduate Course
Number: 116
Disease area: Respiratory infections

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Torres (Barcelona, Spain). Treatment failure of community-acquired pneumonia: risk factors and consequences. Annual Congress 2012 - PG17 Clinical failure of treatment of respiratory infections

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The main risk factors of the community-acquired pneumonia delayed course
Source: Eur Respir J 2005; 26: Suppl. 49, 643s
Year: 2005

Affecting factors of mortality in severe community-acquired pneumonia
Source: Eur Respir J 2005; 26: Suppl. 49, 643s
Year: 2005

Risk factors for early onset severe community-acquired pneumonia complications
Source: International Congress 2018 – Pleural diseases and pneumonia: what's new ?
Year: 2018




Risk factors of community-acquired pneumonia in children
Source: Eur Respir J 2010; 36: 1221-1222
Year: 2010


Incidence, risk factors and outcomes of cardiovascular events in hospitalized patients with community-acquired pneumonia (CAP)
Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Year: 2009

Risk factors of paediatric community-acquired pneumonia
Source: Eur Respir J 2011; 37: 724-725
Year: 2011


Management-based risk prediction in community-acquired pneumonia by scores and biomarkers
Source: Eur Respir J 2013; 41: 974-984
Year: 2013



3-day mortality in hospitalised community-acquired pneumonia: frequency and risk factors
Source: Eur Respir J 2016; 47:1572-1574
Year: 2016


Incidence, risk factors and outcomes of nonresolving pneumonia
Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools
Year: 2010

Community-acquired pneumonia: treatment failure and complications
Source: ERS Course 2018 - Respiratory Infections
Year: 2018

Risk factors of nosocomial pneumonia in multiple trauma patients
Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit
Year: 2018


Risk factors for pulmonary tuberculosis in community-acquired pneumonia
Source: Eur Respir J 2014; 43: 1213
Year: 2014


Risk factors for pulmonary tuberculosis in community-acquired pneumonia
Source: Eur Respir J 2014; 43: 1214
Year: 2014


Risk factors of treatment failure of community acquired pneumonia in patients with COPD
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008


Risk factors for drug-resistant pathogens in patients with hospital-acquired and ventilator-associated pneumonia
Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes
Year: 2017


Incidence and risk factors of MRSA pneumonia
Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia
Year: 2011

Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor
Source: Eur Respir J 2004; 24 : 779-785
Year: 2004



Predictor factors of empirical antimicrobial treatment failure in community-acquired pneumonia
Source: Eur Respir J 2002; 20: Suppl. 38, 357s
Year: 2002

Is community-acquired pneumonia an independent risk factor for cardiovascular disease?
Source: Eur Respir J 2011; 39: 187-196
Year: 2012



Is community-acquired pneumonia an independent risk factor for cardiovascular disease?
Source: Eur Respir J 2012; 39: 187-196
Year: 2012